Observation of rituximab as initial treatment in patients with minimal change disease- a retrospective study

Observation of rituximab as initial treatment in patients with minimal change disease- a retrospective study

Research backgroundThis study was aimed to retrospectively investigate the efficacy and safety of rituximab (RTX) versus glucocorticoids (GC) as initial treatments for patients with minimal change disease (MCD).Research methodsPatients who were diagnosed with MCD through kidney biopsy and received R...

Full description

Saved in:
Bibliographic Details
Main Authors: Sha Wang, Hua Liang, Lu-Yao Li, Miao-Miao Cheng, Fang-Yi Lv, Li Zong, Ke Zhao, Xiao-Yan Xiao, Xiang-Dong Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
rituximab
minimal change disease
glucocorticoid
Nephrotic Syndrome
remission
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1528996/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items